Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Eliem Therapeutics (ELYM) Institutional Ownership

Eliem Therapeutics logo
$1.72 +0.09 (+5.52%)
As of 08/14/2025
Compare

Institutional Ownership Changes (13F Filings) for Eliem Therapeutics (NASDAQ:ELYM)

Current
Institutional Ownership
Percentage
69.76%
Number of
Institutional Buyers
(last 12 months)
19
Total
Institutional Inflows
(last 12 months)
$14.72M
Number of
Institutional Sellers
(last 12 months)
3
Total
Institutional Outflows
(last 12 months)
$4.31M
Get ELYM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Eliem Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

ELYM Institutional Buying and Selling by Quarter

Eliem Therapeutics Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
12/26/2024 JPMorgan Chase & Co.12,776$65K0.0%+311.6%0.043%
11/19/2024 Barclays PLC38,859$198K0.0%+1,428.1%0.131%
11/15/2024 Barclays PLC38,859$198K0.0%+1,428.1%0.131%
11/15/2024Jane Street Group LLC10,907$56K0.0%N/A0.037%
11/15/2024Sphera Funds Management LTD.181,970$926K0.1%-15.4%0.612%
11/15/2024State Street Corp315,036$1.60M0.0%+433.9%1.059%
11/15/2024Samsara BioCapital LLC2,609,114$13.28M2.6%-20.0%8.770%
11/15/2024Point72 Asset Management L.P.590,946$3.01M0.0%N/A1.986%
11/15/2024Parkman Healthcare Partners LLC278,775$1.42M0.2%N/A0.937%
11/15/2024Ikarian Capital LLC175,100$891K0.1%+75.1%0.589%
11/15/2024Janus Henderson Group PLC3,606,495$18.30M0.0%+10.8%12.122%
11/14/2024Ally Bridge Group NY LLC1,229,292$6.26M3.3%+145.9%4.132%
11/14/2024 MetLife Investment Management LLC17,769$90K0.0%N/A0.060%
11/13/2024Great Point Partners LLC248,168$1.26M0.4%N/A0.834%
11/13/2024 Advantage Alpha Capital Partners LP48,169$245K0.1%N/A0.162%
11/13/2024The Manufacturers Life Insurance Company49,524$252K0.0%N/A0.166%
11/12/2024 Valence8 US LP12,045$61K0.0%N/A0.040%
11/12/2024 Charles Schwab Investment Management Inc.70,093$357K0.0%+309.2%0.236%
11/8/2024 Segall Bryant & Hamill LLC58,411$297K0.0%N/A0.196%
10/29/2024 Chicago Partners Investment Group LLC16,966$81K0.0%N/A0.057%
10/3/2024 SG Americas Securities LLC11,715$60K0.0%N/A0.039%
8/16/2024Driehaus Capital Management LLC696,057$4.95M0.0%-14.2%2.340%
8/15/2024 Affinity Asset Advisors LLC1,670,661$11.88M1.4%N/A5.615%
8/14/2024Ally Bridge Group NY LLC500,000$3.56M2.1%N/A1.681%
8/9/2024 Renaissance Technologies LLC37,000$263K0.0%+248.5%0.124%
8/9/2024 Dimensional Fund Advisors LP12,560$89K0.0%N/A0.042%
8/1/2024 Rhumbline Advisers8,233$59K0.0%N/A0.028%
7/26/2024 Bank of New York Mellon Corp18,845$134K0.0%N/A0.063%
4/23/2024 BML Capital Management LLC2,193,742$6.01M4.0%+0.6%7.914%
1/30/2024 BML Capital Management LLC2,180,000$5.89M4.4%+12.5%7.907%
1/26/2024 Cerity Partners LLC13,821$37K0.0%N/A0.050%
11/13/2023Silverarc Capital Management LLC121,110$319K0.1%-75.5%0.447%
10/23/2023 BML Capital Management LLC1,938,263$5.10M4.7%+22.4%7.155%
8/15/2023Silverarc Capital Management LLC494,089$1.38M0.4%+1.7%1.830%
8/14/2023Driehaus Capital Management LLC810,593$2.27M0.0%+20.3%3.003%
7/24/2023 BML Capital Management LLC1,583,170$4.43M4.0%-4.5%5.866%
4/14/2023 BML Capital Management LLC1,658,170$4.81M4.2%-9.1%6.148%
2/14/2023Driehaus Capital Management LLC551,942$2.03M0.0%+58.3%2.077%
2/13/2023 BML Capital Management LLC1,825,134$6.70M6.4%N/A6.869%
2/1/2023 Bank of Montreal Can25,244$93K0.0%N/A0.095%
This stock could leave NVDA in the dust (Ad)

Investing Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.

Click to get the full details on Eric Fry's "Nvidia alternative" right here.
11/8/2022Atom Investors LP67,074$217K0.1%+154.9%0.252%
10/28/2022Silverarc Capital Management LLC402,088$1.30M0.4%-43.6%1.513%
8/16/2022Parkwood LLC67,202$67K0.2%+63.4%0.253%
7/25/2022Silverarc Capital Management LLC713,009$2.15M0.7%+707.7%2.684%
5/12/2022 Monashee Investment Management LLC227,201$1.91M0.6%-24.3%0.855%
5/9/2022Qube Research & Technologies Ltd15,874$133K0.0%N/A0.060%
2/19/2022Woodline Partners LP373,368$3.91M0.1%-3.6%1.406%
2/15/2022Samlyn Capital LLC1,703,546$17.82M0.2%+1.3%6.417%
2/11/2022Parkwood LLC30,609$320K0.1%N/A0.115%
2/7/2022 Monashee Investment Management LLC300,000$3.14M0.8%-1.7%1.130%
2/2/2022 New York State Common Retirement Fund3,359$35K0.0%N/A0.013%
1/28/2022 Allspring Global Investments Holdings LLC2,880$30K0.0%N/A0.011%
12/29/2021Hudson Bay Capital Management LP100,000$1.80M0.0%N/A0.377%
11/15/2021Tudor Investment Corp Et Al287,294$5.17M0.0%N/A1.082%
11/15/2021RA Capital Management L.P.13,150,849$236.45M3.3%N/A49.536%
11/15/2021Caas Capital Management LP75,000$1.35M0.0%N/A0.283%
11/12/2021 Geode Capital Management LLC76,904$1.38M0.0%N/A0.290%
11/10/2021Goldman Sachs Group Inc.165,952$2.98M0.0%N/A0.625%
11/9/2021BlackRock Inc.332,126$5.97M0.0%N/A1.251%
11/9/2021 Monashee Investment Management LLC305,233$5.49M1.0%N/A1.150%
11/4/2021 Deutsche Bank AG4,063$73K0.0%N/A0.015%
(Data available from 1/1/2016 forward)

ELYM Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ELYM shares?

During the previous two years, 29 institutional investors and hedge funds held shares of Eliem Therapeutics. The most heavily invested institutionals were Janus Henderson Group PLC ($18.30M), Samsara BioCapital LLC ($13.28M), Affinity Asset Advisors LLC ($11.88M), Ally Bridge Group NY LLC ($6.26M), BML Capital Management LLC ($6.01M), Driehaus Capital Management LLC ($4.95M), and Point72 Asset Management L.P. ($3.01M).Learn more on Eliem Therapeutics' institutional investors.

What percentage of Eliem Therapeutics' stock is owned by institutional investors?

69.76% of Eliem Therapeutics' stock is owned by institutional investors. Learn more on ELYM's institutional investor holdings.

Which institutional investors have been buying Eliem Therapeutics' stock?

Of the 26 institutional investors that purchased Eliem Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Affinity Asset Advisors LLC ($1.67M), Ally Bridge Group NY LLC ($1.23M), BML Capital Management LLC ($610.57K), Point72 Asset Management L.P. ($590.95K), Janus Henderson Group PLC ($352.51K), Parkman Healthcare Partners LLC ($278.78K), and State Street Corp ($256.03K).

How much institutional buying is happening at Eliem Therapeutics?

Institutional investors have bought a total of 2,891,592 shares in the last 24 months. This purchase volume represents approximately $14.72M in transactions.

Which of Eliem Therapeutics' major shareholders have been selling company stock?

The following institutional investors have sold Eliem Therapeutics stock in the last 24 months: Samsara BioCapital LLC ($652.28K), Driehaus Capital Management LLC ($115.62K), and Sphera Funds Management LTD. ($33.21K).

How much institutional selling is happening at Eliem Therapeutics?

Institutional investors have sold a total of 801,111 shares in the last 24 months. This volume of shares sold represents approximately $4.31M in transactions.


Related Companies

This page (NASDAQ:ELYM) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump c...
Weiss Ratings | Sponsored
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsored
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsored
Crypto Income (almost instantly)
How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...
Awesomely, LLC | Sponsored
Critical AI announcement set to ignite AI 2.0
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored
New Federal Land Rush About to Start?
A $100 Trillion Wealth Shift Is Already Underway Lithium. Oil. Gold. Trillions in U.S. resources are being ...
Stansberry Research | Sponsored